| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
COLONSEQ Panel : 1004878
MessagePlease provide most recent Pathology report.
Test Code
MDFCPNGSCC1P or 1004878
Alias/See Also
ColonSEQ by NGS
CPT Codes
81457
Includes
COLONSEQ Panel Components: BRAF (p.V600E); KRAS (p.G12C/S/R/V/A/D, p.G13C/S/R/D/A, p.Q61R/K/L/H, p.K117N, p.A146T/P/V); NRAS (p.G12C/S/A/D/V, p.G13R/C/D/V, p.Q61K/L/R); PIK3CA (p.E542K, p.E545K/Q/A/G/V, p.Q546K/E/P/R/L, p.H1047R/L); PTEN (p.R233X), and Microsatellite Instability (MSI) by PCR.
If you have any further questions, additional needs, or would like to speak with med fusion’s scientific staff, pathologists, or client services, please contact us at 972-966-7050/844-966-7050.
If you have any further questions, additional needs, or would like to speak with med fusion’s scientific staff, pathologists, or client services, please contact us at 972-966-7050/844-966-7050.
Instructions
Tissue.
Transport Container
Paraffin embedded Tissue accompanied by a circled H & E slide indicating the area to be examined: submit in sterile biohazard plastic bag. Slides: submit 15 FFPE slides and 1 H & E slide (or one additional slide) in slide holder. Specimen to be tested must contain a minimum of 10 percent tumor.
Transport Temperature
Paraffin embedded Tissue: Ambient or on ice pack in summer; Slides: Ambient.
Specimen Stability
Paraffin embedded tissue: Ambient: Indefinitely; Refrigerated: Indefinitely; Frozen: Unacceptable
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Decalcified tissue specimen.
Methodology
Next Generation Sequencing and PCR (MSI)
Setup Schedule
Monday & Thursday
Report Available
8-10 days
Limitations
Laboratory test results should always be considered in the context of clinical observations. This test was developed and its performance characteristics determined by med fusion. It has not been cleared or approved by the U.S. Food and Drug Administration
(FDA). The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be regarded as investigational for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments
of 1988 (CLIA) as qualified to perform high complexity clinical laboratory testing.
(FDA). The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be regarded as investigational for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments
of 1988 (CLIA) as qualified to perform high complexity clinical laboratory testing.
Reference Range
An interpretive report will be provided.
Clinical Significance
This test is intended to be used as a disease specific solid tumor panel to aid the oncologist in prioritizing standard of care therapy choices for their patients with Colorectal Cancer.
Performing Laboratory
med fusion
